Integral Health Asset Management as of Dec. 31, 2025
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 84 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 10.8 | $218M | 1.3M | 174.04 | |
| Cytokinetics Com New Call Option (CYTK) | 6.0 | $121M | 1.9M | 63.54 | |
| Revolution Medicines (RVMD) | 4.7 | $96M | 1.2M | 79.65 | |
| Vera Therapeutics Cl A (VERA) | 4.5 | $91M | 1.8M | 50.64 | |
| Regeneron Pharmaceuticals (REGN) | 4.0 | $81M | 105k | 771.87 | |
| Medtronic SHS (MDT) | 3.2 | $65M | 675k | 96.06 | |
| Intuitive Surgical Com New (ISRG) | 3.1 | $62M | 110k | 566.36 | |
| Rhythm Pharmaceuticals (RYTM) | 2.5 | $51M | 475k | 107.04 | |
| Alignment Healthcare (ALHC) | 2.2 | $44M | 2.2M | 19.75 | |
| Cardinal Health (CAH) | 2.0 | $41M | 200k | 205.50 | |
| CVS Caremark Corporation (CVS) | 2.0 | $40M | 500k | 79.36 | |
| Edgewise Therapeutics (EWTX) | 1.8 | $37M | 1.5M | 24.82 | |
| Glaukos (GKOS) | 1.8 | $37M | 325k | 112.91 | |
| Mineralys Therapeutics Call Option (MLYS) | 1.8 | $36M | 1.0M | 36.29 | |
| Novartis Sponsored Adr (NVS) | 1.7 | $35M | 250k | 137.87 | |
| Dex (DXCM) | 1.6 | $33M | 500k | 66.37 | |
| Astrazeneca Sponsored Adr | 1.6 | $32M | 350k | 91.93 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 1.5 | $31M | 1.0M | 31.21 | |
| Penumbra (PEN) | 1.5 | $31M | 100k | 310.91 | |
| Teleflex Incorporated (TFX) | 1.5 | $31M | 250k | 122.04 | |
| Brightspring Health Svcs (BTSG) | 1.4 | $28M | 750k | 37.45 | |
| Edwards Lifesciences (EW) | 1.4 | $28M | 325k | 85.25 | |
| Centene Corporation (CNC) | 1.3 | $27M | 650k | 41.15 | |
| Cooper Cos (COO) | 1.3 | $27M | 325k | 81.96 | |
| Merck & Co (MRK) | 1.3 | $26M | 250k | 105.26 | |
| Alnylam Pharmaceuticals (ALNY) | 1.2 | $24M | 60k | 397.65 | |
| Irhythm Technologies (IRTC) | 1.1 | $23M | 130k | 177.44 | |
| Uniqure Nv SHS (QURE) | 1.1 | $22M | 900k | 23.93 | |
| Eli Lilly & Co. (LLY) | 1.1 | $22M | 20k | 1074.68 | |
| Boston Scientific Corporation (BSX) | 1.1 | $22M | 225k | 95.35 | |
| Neurocrine Biosciences (NBIX) | 1.1 | $21M | 150k | 141.83 | |
| Lifestance Health Group (LFST) | 1.0 | $21M | 3.0M | 7.04 | |
| Anthem (ELV) | 1.0 | $21M | 60k | 350.55 | |
| Upstream Bio (UPB) | 1.0 | $20M | 750k | 27.15 | |
| Tenet Healthcare Corp Com New (THC) | 1.0 | $20M | 100k | 198.72 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.0 | $19M | 90k | 213.24 | |
| Roivant Sciences SHS (ROIV) | 0.9 | $18M | 850k | 21.70 | |
| Doximity Cl A (DOCS) | 0.9 | $18M | 400k | 44.28 | |
| Biogen Idec (BIIB) | 0.9 | $18M | 100k | 175.99 | |
| Regenxbio Inc equity us cm (RGNX) | 0.9 | $17M | 1.2M | 14.40 | |
| Terns Pharmaceuticals (TERN) | 0.9 | $17M | 425k | 40.40 | |
| Biohaven (BHVN) | 0.8 | $17M | 1.5M | 11.29 | |
| UnitedHealth (UNH) | 0.8 | $17M | 50k | 330.11 | |
| Tarsus Pharmaceuticals (TARS) | 0.8 | $16M | 200k | 81.88 | |
| Fresenius Medical Care Sponsored Adr (FMS) | 0.8 | $16M | 650k | 23.82 | |
| Beam Therapeutics (BEAM) | 0.8 | $15M | 550k | 27.72 | |
| Soleno Therapeutics (SLNO) | 0.7 | $15M | 325k | 46.30 | |
| RadNet (RDNT) | 0.7 | $14M | 200k | 71.35 | |
| Scholar Rock Hldg Corp (SRRK) | 0.7 | $13M | 300k | 44.05 | |
| Arcellx Common Stock (ACLX) | 0.6 | $13M | 200k | 65.20 | |
| Quest Diagnostics Incorporated (DGX) | 0.6 | $13M | 75k | 173.53 | |
| Sana Biotechnology (SANA) | 0.6 | $12M | 3.0M | 4.07 | |
| Protara Therapeutics Com Stk (TARA) | 0.6 | $12M | 2.3M | 5.33 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.6 | $12M | 40k | 294.74 | |
| Dianthus Therapeutics (DNTH) | 0.6 | $11M | 275k | 41.21 | |
| Envista Hldgs Corp (NVST) | 0.5 | $11M | 500k | 21.71 | |
| Encompass Health Corp (EHC) | 0.5 | $11M | 100k | 106.14 | |
| Oric Pharmaceuticals (ORIC) | 0.5 | $9.8M | 1.2M | 8.18 | |
| Charles River Laboratories (CRL) | 0.4 | $9.0M | 45k | 199.48 | |
| Celcuity (CELC) | 0.4 | $8.0M | 80k | 99.74 | |
| Inspire Med Sys (INSP) | 0.3 | $6.9M | 75k | 92.23 | |
| Alto Neuroscience Com Shs (ANRO) | 0.3 | $6.7M | 375k | 17.80 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.3 | $6.7M | 100k | 66.55 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.3 | $6.6M | 100k | 66.39 | |
| Bruker Corporation (BRKR) | 0.3 | $5.9M | 125k | 47.11 | |
| Nurix Therapeutics (NRIX) | 0.3 | $5.7M | 300k | 18.97 | |
| Elanco Animal Health (ELAN) | 0.3 | $5.7M | 250k | 22.63 | |
| Apellis Pharmaceuticals (APLS) | 0.2 | $5.0M | 200k | 25.12 | |
| Rezolute Com New (RZLT) | 0.2 | $4.7M | 2.0M | 2.36 | |
| Mind Medicine Mindmed Com New (MNMD) | 0.2 | $4.7M | 350k | 13.39 | |
| Syndax Pharmaceuticals (SNDX) | 0.2 | $4.2M | 200k | 21.01 | |
| Maze Therapeatics (MAZE) | 0.2 | $4.1M | 100k | 41.43 | |
| Eyepoint Com New (EYPT) | 0.2 | $3.7M | 200k | 18.27 | |
| Inhibikase Therapeutics Com New (IKT) | 0.2 | $3.6M | 1.8M | 2.05 | |
| Viking Therapeutics (VKTX) | 0.2 | $3.5M | 100k | 35.18 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.2 | $3.5M | 50k | 69.55 | |
| Sight Sciences (SGHT) | 0.2 | $3.4M | 425k | 7.93 | |
| Gossamer Bio (GOSS) | 0.2 | $3.1M | 1.0M | 3.10 | |
| Oscar Health Cl A (OSCR) | 0.1 | $2.9M | 200k | 14.37 | |
| Lb Pharmaceuticals Com Shs (LBRX) | 0.1 | $2.2M | 100k | 22.26 | |
| Evommune Com Shs (EVMN) | 0.1 | $2.1M | 125k | 17.12 | |
| Tenax Therapeutics Com New (TENX) | 0.1 | $2.0M | 167k | 12.19 | |
| Tango Therapeutics (TNGX) | 0.1 | $1.8M | 200k | 8.86 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $1.6M | 200k | 7.80 |
